Do you see suspension reaching a point soon where the specific productivity is better than adherent systems?


I think we’re already there. Our VirusExpress Lentivirus Production platform has been shown to outperform adherent systems (by as much as 5x)  with regards to overall titer and specific productivity. Future enhancements  such as the optimization of transfection process,  the introduction of better transfection reagents, and improved parameters used for the growth of cells, will continue to improve the overall productivity.

Pin It on Pinterest